Macquarie Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118M | Sell |
|
|||||
|
2025
Q1 | $114M | Buy |
|
|||||
|
2024
Q4 | $110M | Sell |
|
|||||
|
2024
Q3 | $117M | Sell |
|
|||||
|
2024
Q2 | $141M | Buy |
|
|||||
|
2024
Q1 | $124M | Sell |
|
|||||
|
2023
Q4 | $145M | Sell |
|
|||||
|
2023
Q3 | $79.3M | Buy |
|
|||||
|
2023
Q2 | $95.9M | Buy |
|
|||||
|
2023
Q1 | $67.4M | Buy |
|
|||||
|
2022
Q4 | $57.4M | Buy |
|
|||||
|
2022
Q3 | $84.8M | Buy |
|
|||||
|
2022
Q2 | $64.4M | Buy |
|
|||||
|
2022
Q1 | $78.8K | Sell |
|
|||||
|
2021
Q4 | $137M | Sell |
|
|||||
|
2021
Q3 | $133M | Buy |
|
|||||
|
2021
Q2 | $102M | Buy |
|
|||||
|
2021
Q1 | $81.8M | Buy |
|
|||||
|
2020
Q4 | $93.6M | Buy |
|
|||||
|
2020
Q3 | $70.5M | Buy |
|
|||||
|
2020
Q2 | $15.4M | Buy |
|
|||||
|
2020
Q1 | $1.65M | Buy |
|
|||||
|
2019
Q4 | $1M | Sell |
|
|||||
|
2019
Q3 | $8.64M | Buy |
|